Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, March 10, 2015

Hepatitis C: Asunaprevir/Daclatasvir National Patient Consultation Webinar

Asunaprevir/Daclatasvir National Patient Consultation Webinar
Published on Mar 9, 2015
Now under review by the Common Drug Review (CDR), these two separate treatments for chronic hepatitis C are presently in the patient-input stage of the review process.





No comments:

Post a Comment